Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study
This study highlights the increasing trend toward conservative and less invasive surgeries in resected NSCLC. Type of LR can be used as an indirect marker of disease expansion, with poorer survival outcomes in case of extensive surgeries.
Authors
- Paul Casabianca (ORCID: https://orcid.org/0009-0001-9980-5807)
- C. Chouaïd (ORCID: https://orcid.org/0000-0002-4290-5524)
- M. Chartier (ORCID: https://orcid.org/0000-0003-2469-920X)
- Stéphane Renaud (ORCID: https://orcid.org/0000-0002-4448-7696)
- Stève Bénard (ORCID: https://orcid.org/0000-0002-9799-1757)
- Anne-Françoise Gaudin (ORCID: https://orcid.org/0000-0002-6946-2479)
- François-Emery Cotté (ORCID: https://orcid.org/0000-0002-6758-4552)
- Françoise Bugnard
- Pauline Diez-Andreu
Institutions
- Bristol-Myers Squibb (France) (FR)
- Centre d’Investigation Clinique Innovation Technologique de Nancy (FR)
- Hôpital Intercommunal de Créteil (FR)
- Geosciences Consultants (FR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1186/s12885-025-14334-2
- Citations
- 3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Bristol-Myers Squibb